SCHEMBL5752434

SCHEMBL5752434

CCOC(=O)C(Cc1ccc(C(F)(F)F)o1)C(=O)c1ccc(F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.38
PPARG P37231 3/20 0.38
MAPT P10636 5/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
CASP3 P42574 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
KDM4E B2RXH2 4/20 0.34
GAA P10253 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
ALDH1A1 P00352 4/20 0.34
LMNA P02545 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
SLC6A4 P31645 1/20 0.33
CES2 O00748 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20543879 0.77 GRM8 (0.39) EPHX2PPARGMAPTKDM4EGAA
SCHEMBL5751205 0.77 PPARG (0.54) EPHX2PPARGMAPT
SCHEMBL5751165 0.77 PPARG (0.54) EPHX2PPARGMAPT
SCHEMBL5748807 0.77 EPHX2 (0.54) EPHX2PPARGMAPTKMT2AMEN1
SCHEMBL5755917 0.75 EPHX2 (0.51) EPHX2PPARGKDM4EALDH1A1SLC6A4
SCHEMBL5749775 0.75 EPHX2 (0.35) EPHX2PPARGMAPTKMT2AMEN1
SCHEMBL5752707 0.74 TRPM8 (0.36) EPHX2PPARGMAPTKMT2AMEN1
SCHEMBL5750744 0.74 EPHX2 (0.49) EPHX2PPARGMAPTKMT2AMEN1
SCHEMBL5752663 0.74 MDM2 (0.60) MAPTKDM4EALDH1A1LMNACYP1A2
SCHEMBL5750115 0.74 PPARG (0.46) EPHX2PPARGMAPTALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6982348-B2 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-01-03 US disclosed
US-20040127574-A1 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-07-01 US disclosed
EP-1362846-A1 AMINOETHANOL DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127574-A1 Aminoethanol derivatives CETP, LCAT, MTTP EPHX2 1434/4885PPARG 905/4885MAPT 2688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.